Bessho K, Iizuka T
Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kyoto University, Japan.
Br J Oral Maxillofac Surg. 1994 Apr;32(2):86-90. doi: 10.1016/0266-4356(94)90134-1.
Bone morphogenetic protein (BMP) was extracted from porcine bone matrix and purified by liquid chromatography. The final purified fraction was shown to be homogeneous by sodium dodecyl sulfate-polyacrylamide slab gel electrophoresis (SDS-PAGE). The molecular weight of porcine bone matrix-derived BMP was estimated to be about 20 kDa by SDS-PAGE. The final purified BMP was highly soluble in vivo, so that it dispersed immediately after implantation and exerted no effect on bone induction. The other crude active fractions obtained in the process of purification induced new bone in three weeks when implanted into muscle pouches of Wistar rats. These findings suggested that pure BMP requires an appropriate carrier (delivery system) for clinical use; hence, experiments using atelopeptide type-I collagen as carrier were conducted.
骨形态发生蛋白(BMP)从猪骨基质中提取,并通过液相色谱法进行纯化。通过十二烷基硫酸钠 - 聚丙烯酰胺平板凝胶电泳(SDS - PAGE)显示,最终纯化的部分是均一的。通过SDS - PAGE估计,猪骨基质衍生的BMP的分子量约为20 kDa。最终纯化的BMP在体内高度可溶,因此植入后立即分散,对骨诱导没有作用。在纯化过程中获得的其他粗活性部分,植入Wistar大鼠的肌肉袋中三周后可诱导新骨形成。这些发现表明,纯BMP在临床应用中需要合适的载体(递送系统);因此,进行了使用I型去端肽胶原蛋白作为载体的实验。